
Vetoquinol
VETO · PA · Healthcare / Drug Manufacturers - Specialty & Generic
87.20EUR-1.30 (-1.47%)
Price History
Full chartMarket Stats
Previous Close88.50
Open88.60
Day Range86.20 – 89.10
52-Week Range65.70 – 90.27
Volume5.59K
Market Cap883.47M
P/E (TTM)13.97
Forward P/E16.34
EPS5.44
Dividend Yield1.26%
Beta0.83
50-Day Avg72.25
200-Day Avg76.65
About
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Matthieu Frechin
- Employees2.53K
- HeadquartersMagny-Vernois, Lure, France, 70204, France
- Websitehttps://www.vetoquinol.com
Leadership
- Mr. Matthieu FrechinCEO & Non-Independent Chairman of the Board · b. 1969
- Mr. Dominique DerveauxChief Operations Officer & Group Deputy CEO · b. 1969
- Mr. Alain MassonDeputy CEO & Pharmacist Manager · b. 1962
- Mr. Regis Vimal du MonteilChief Financial Officer · b. 1965
- Philippe GruetChief Scientific Officer
- Sandrine PerrierChief Information Officer
- Laurent ThoreDirector of Partnerships, Legal Affairs & Risks
- Xavier BerthetDirector of Group Communications
- Ms. Nathalie ArlecchiniGroup Human Resources Director
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap883.47M
Enterprise Value637.00M
Trailing P/E13.97
Forward P/E16.34
PEG Ratio3.80
Price / Sales1.68
Price / Book1.43
EPS5.44
Book Value52.48
Revenue (TTM)527.34M
Gross Profit (TTM)311.69M
EBITDA107.26M
Profit Margin11.92%
Operating Margin15.11%
Return on Equity10.68%
Return on Assets7.04%
Shares Outstanding11.62M
Shares Float3.65M
Beta0.83
Dividend Yield1.26%
Dividend Rate0.93
Payout Ratio17.10%
Dividends
20261×
0.93Jun 3, 2026
20251×
0.89Jun 4, 2025
20241×
0.85Jun 4, 2024
20231×
0.80Jun 2, 2023
20221×
0.80Jun 3, 2022
20211×
0.50Jun 4, 2021
20201×
0.38Jun 2, 2020
20191×
0.48May 31, 2019
20181×
0.46Jun 4, 2018
20171×
0.43Jun 2, 2017
20161×
0.41Jun 2, 2016
20151×
0.39Jun 2, 2015
20141×
0.37Jun 2, 2014
20131×
0.35Jun 3, 2013
20121×
0.33May 31, 2012
20111×
0.30Jun 1, 2011
20101×
0.29Jun 1, 2010
20091×
0.27Jun 2, 2009
20081×
0.27Jun 5, 2008
20071×
0.23Jun 8, 2007